Sermorelin

From Wikipedia, the free encyclopedia - View original article

Sermorelin
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
Pregnancy cat. ?
Legal status ?
Identifiers
CAS number86168-78-7 YesY
ATC codeH01AC04 V04CD03
PubChemCID 16132413
DrugBankDB00010
UNII89243S03TE N
KEGGD08509 YesY
ChEMBLCHEMBL1201490 N
Chemical data
FormulaC149H246N44O42S 
Mol. mass3357.882
 N (what is this?)  (verify)
 
Jump to: navigation, search
Sermorelin
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
Pregnancy cat. ?
Legal status ?
Identifiers
CAS number86168-78-7 YesY
ATC codeH01AC04 V04CD03
PubChemCID 16132413
DrugBankDB00010
UNII89243S03TE N
KEGGD08509 YesY
ChEMBLCHEMBL1201490 N
Chemical data
FormulaC149H246N44O42S 
Mol. mass3357.882
 N (what is this?)  (verify)

Sermorelin, sometimes called GRF 1-29, is a growth hormone releasing hormone analogue. It is a 29-amino acid polypeptide representing the 1-29 fragment from endogenous human growth hormone releasing hormone, and is thought to be the shortest fully functional fragment of GHRH.[1] It is used as a test for growth hormone secretion.[2] It is also used as doping substance in sports.[citation needed]

See also[edit]

References[edit]

  1. ^ Prakash A, Goa KL (August 1999). "Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency". BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 12 (2): 139–57. PMID 18031173. 
  2. ^ Pharmacology (Rang, Dale, Ritter & Moore, ISBN 0-443-07145-4, 5:th ed., Churchill Livingstone 2003).